NSE filing, NSE: ONYX. Summary written from the filing by ALFA Finder's alert engine.
Onyx Biotec Ltd: key numbers
- Share price
- ₹36.00
- Market cap
- ₹65.28 Cr
- Revenue (annual)
- ₹69.47 Cr
- Net profit (annual)
- ₹-0.21 Cr
- P/E (TTM)
- -304.5×Sector 46.1×
- Promoter holding
- 41.74%
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Onyx Biotec Ltd
All →Onyx Biotec Other Announcement
Onyx Biotec Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Onyx Biotec Open Offer
Onyx Biotec's Committee of Independent Directors met to review the open offer by the identified acquirers to purchase 26% of the company's equity share capital.
Onyx Biotec Open Offer: ₹17.21 Cr
Bhardwaj acquirers launch a ₹172.07 Crore open offer for 26% of Onyx Biotec at ₹36.5 per share. Tendering runs October 13–27, 2026.
- Value
- ₹17.21 Cr
Onyx Biotec Annual General Meeting
Onyx Biotec Limited held its 21st Annual General Meeting on September 28, 2026. The meeting covered standard agenda items including financial statement adoption and director appointments.
Onyx Biotec Annual General Meeting
Onyx Biotec Limited will hold its 21st Annual General Meeting on September 28, 2026, via video conferencing to transact the company's business.
Onyx Biotec Management Change
Onyx Biotec Limited has announced a change in the designation of Mr. Naresh Kumar from Whole-Time Director to Executive Director, effective September 3, 2026.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.